Assistant Professor, Urology, Baylor College of Medicine
Urology
Dr. Gilad E. Amiel, MD
|
|
Give Review
Gilad E. Amiel, MD is an expert in the field of Urology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Gilad E. Amiel is a published doctor as well. He has 51 publications published. The latest was: Urine cytology, tumour markers and bladder cancer. Gilad E. Amiel accepts Medicare.
Publications
- External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
- Usefulness of transUrethral biopsy for staging the prostatic urethra before radical cystectomy.
- Examining sexual dysfunction in non-muscle-invasive Bladder cancer: results of cross-sectional mixed-methods research.
- Educational Opportunities in Bladder Cancer: Increasing Cystoscopic Adherence and the Availability of Smoking-Cessation Programs.
- Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
- Alvimopan, a peripherally acting mu-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, c...
- Comprehensive handbook for developing a Bladder cancer cystectomy database.
- Racial/ethnic differences in upper-tract urothelial Cancer.
- Prognostic risk stratification of pathological stage T3N0 Bladder cancer after radical cystectomy.
- Prognostic risk stratification of pathological stage T2N0 Bladder cancer after radical cystectomy.
- Urologists' Attitudes Regarding Information Sharing with Prostate Cancer Patients-Is There a Common Ground for Collaboration with Family Physicians?
- Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 Bladder cancer.
- Outcomes of radical cystectomy for transitional cell carcinoma of the Bladder: a contemporary series from the Bladder Cancer Research Consortium.
- Nomograms provide improved accuracy for predicting survival after radical cystectomy.
- Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
- Newer modalities of ultrasound imaging and treatment of the Prostate.
- Engineering of Blood vessels from acellular collagen matrices coated with human endothelial cells.
- Febrile complications following insertion of 100 double-J Ureteral stents.
- What's new in Cancer education research.
- Alternatives to cytology in the management of non-muscle invasive Bladder cancer.
- Performance assessment of community-based physicians: evaluating the reliability and validity of a tool for determining CME needs.
- Bladder tumor antigen stat test in non-urothelial malignant urologic conditions.
- Lymphovascular invasion is independently associated with overall survival, cause-Specific survival, and local and distant recurrence in patients with negative lymph no...
- Prostatic involvement by transitional cell carcinoma in patients with Bladder cancer and its prognostic significance.
- Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
- [A structured course for primary care physicians on breaking bad news].
- Breaking bad news: structured training for family medicine residents.
- [The challenge: diagnosis and treatment of Chronic scrotal pain].
- Using an OSCE to assess primary care physicians' competence in breaking bad news.
- Renal therapy using tissue-engineered constructs and gene delivery.
- Use of N-butyl-2-cyanoacrylate in elective surgical incisions--longterm outcomes.
- Current and future modalities for functional Renal replacement.
- Urine cytology, tumour markers and Bladder cancer.
- Increasing examiner involvement in an objective structured clinical examination by integrating a structured oral examination.
- Using a video conference to teach clinical clerks in a one-week cardiothoracic clerkship.
- Variability in the clinical skills of residents entering training programs in surgery.
- Assessment of emergency medicine: a comparison of an experimental objective structured clinical examination with a practical examination.
- Combining surgery and chemotherapy for invasive Bladder cancer: current and future directions.
- Ability of primary care physician''s to break bad news: a performance based assessment of an educational intervention.
- Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.
- Tissue engineered stents created from chondrocytes.
- Precystectomy nomogram for prediction of advanced Bladder cancer stage.
- [The Objective Structured Clinical Examination and its potential applications as an assessment and feedback tool for IDF primary care physicians--a pilot study].
- Advanced age is associated with poorer Bladder cancer-specific survival in patients treated with radical cystectomy.
- Biocompatible materials for Bladder substitution.
- Neoadjuvant chemotherapy preceding cystectomy for Bladder cancer.
- Adjuvant chemotherapy for Bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
- Blood vessel matrix: a new alternative for abdominal wall reconstruction.
- Family physicians'' perceptions, beliefs, and attitudes regarding information sharing with prostate Cancer patients throughout the course of the disease.
- Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Baylor St. Luke's Medical Center -
Michael E. DeBakey Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1164593869 | |
| NPPES Provider LastName | AMIEL | |
| NPPES Provider FirstName | GILAD | |
| NPPES Provider ZIPCode | 770302348 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 376.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 7.71 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164593869 |
| Last Name Of The Provider | AMIEL |
| First Name Of The Provider | GILAD |
| View All |
Similar Doctors
|
Dr. Patricio C. Gargollo, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Howard R. Lippman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tony McClung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tin C. Ngo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra J. Alexander, MD |
|
|
Dr. Masahito Saitoh, MD |